Myelodysplastic Syndrome (MDS) Clinical Trials

Find Myelodysplastic Syndrome (MDS) Clinical Trials Near You

The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A Multisite, Longitudinal Trial

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to learn about the impact that the services and programs provided by Blood Cancer United (formerly, The Leukemia and Lymphoma Society) have among patients with blood cancer, such as access to care, quality of life, and financial burden.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Be diagnosed with, or have a recurrence of leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN).

• Have received, be receiving, or be planning to receive primary or relapse treatment for leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN) and meet at least one of the following criteria:

‣ Be currently receiving treatment which started within the past 18 months OR

⁃ Be planning to start treatment within one month OR

⁃ Have received Bone Marrow Transplant or CAR-T cell therapy within the past 100 days.

• Not be currently participating in any LLS programs or services

• Be willing to be followed for 6 months

• Speak English or Spanish

Locations
United States
Florida
Sylvester Comprehensive Cancer Center
RECRUITING
Miami
Illinois
University of Chicago Comprehensive Cancer Center
NOT_YET_RECRUITING
Chicago
Texas
Mays Cancer Center at UT Health San Antonio
NOT_YET_RECRUITING
San Antonio
Contact Information
Primary
Carlos Melara, MD
cam32407@med.miami.edu
3052438300
Backup
Sara Fleszar-Pavlovic, PhD
sarafleszarpavlovic@med.miami.edu
Time Frame
Start Date: 2025-02-04
Estimated Completion Date: 2027-07-01
Participants
Target number of participants: 400
Treatments
Experimental: LLS Program and Usual Care Group
Participants in the LLS Program and Usual Care condition will receive LLS services such as information, services, and financial aid so that patients can have better access to healthcare and better quality of life. Participants will also receive the standard care. Participants will be in this group for 6 months.
No_intervention: Usual Care Group
Participants will receive the standard care. Participants will be in this group for 6 months.
Sponsors
Collaborators: Blood Cancer United
Leads: University of Miami

This content was sourced from clinicaltrials.gov

Similar Clinical Trials